Phase I study of the preventive effect of Kampo medicine on oxaliplatin-induced peripheral neurotoxicity
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2631410
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: During XELOX regimen, Kampo medicine is administered as follows: Level 1(TJ-18 7.5g, TJ-3023 0g), Level 2(TJ-18 7.5g, TJ-3023 1.5g), Level 3(TJ-18 7.5g, TJ-3023 3.0g)
Primary outcome(s): Decision of DLT, MTD, RD of Kampo medicine (TJ-3023, TJ-18)
Study Design: Single arm Non-randomized
创建时间：
2014-12-15
